首页> 外文OA文献 >Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies The OVERCOME Trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)

【2h】

Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies The OVERCOME Trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)

机译：依那普利和卡维地洛预防恶性血液病患者化疗引起的左心室收缩功能障碍OVERCOME试验（使用依那普利和卡维地洛预防左心室功能不全患者接受强化化学疗法治疗恶性血液病的方法）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Bosch Xavier; Rovira Montserrat; Sitges Marta; Domènech Ariadna; Ortiz-Pérez José T.; de Caralt Teresa M.; Morales-Ruiz Manuel; Perea Rosario J.; Monzó Mariano; Esteve Jordi;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Bosch, et al., Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (prevention of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive Chemotherapy for the treatment of Malignant hEmopathies). JACC 61 (2013) 2355-2362. [J] . Manish Bansal Indian heart journal . 2013,第5期

机译：Bosch等人，依那普利和卡维地洛可预防恶性血液病患者化疗引起的左心室收缩功能障碍。 OVERCOME试验（使用恩那普利和卡维地洛预防左心室功能不全的患者，应接受强化化学疗法治疗恶性血液病）。 JACC 61（2013）2355-2362。
2. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: The OVERCOME trial (prevention of left ventricular dysfunction with enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of malignant hEmopathies) [J] . BoschX., RoviraM., SitgesM., Journal of the American College of Cardiology . 2013,第23期

机译：Enalapril和Carvedilol用于防止化疗诱导恶性血液疗效患者的左心室收缩功能障碍：克服试验（预防左心室功能障碍，患有Enalapril和Carvedilol的患者，患者治疗恶性血液疗法的患者）
3. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: The OVERCOME trial (prevention of left ventricular dysfunction with enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of malignant hEmopathies) [J] . BoschX., RoviraM., SitgesM., Journal of the American College of Cardiology . 2013,第23期

机译：依那普利和卡维地洛预防恶性血液病患者化疗引起的左心室收缩功能障碍：OVERCOME试验（使用依那普利和卡维地洛预防左心室功能不全的患者接受强化化学疗法治疗恶性血液病）
4. Identification of left ventricular systolic dysfunction and contraction inhomogeneity in post-infarction patients using a segmental two-parameter empirical deformable model [C] . Chen Onn Leong, Jahanzad Zeinab, Einly Lim, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2015

机译：使用分段两参数经验可变形模型鉴定梗死后患者的左心室收缩功能障碍和收缩不均匀
5. Exercise prescription in patients with left ventricular dysfunction: A comparison of conventional methods of exercise prescription with a method utilizing respiratory measures and a Doppler assessment of left ventricular function. [D] . Normandin, Edgar Albert. 1989

机译：左心功能不全患者的运动处方：传统运动处方方法与利用呼吸测量和多普勒评估左心功能的方法的比较。
6. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies) [O] . Manish Bansal 2013

机译：依那普利和卡维地洛可预防恶性血液病患者化疗引起的左心室收缩功能障碍。 OVERCOME试验（使用恩那普利和卡维地洛预防左心室功能不全的患者接受强力化学疗法治疗恶性血液病的患者）
7. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies) BoschEnalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies. The OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)JACC61201323552362 [O] . Bansal Manish 2013

机译：依那普利和卡维地洛可预防恶性血液病患者化疗引起的左心室收缩功能障碍。 OVERCOME试验（在接受加强化疗以治疗恶性血液病的患者中，采用Enalapril和caRvedilol预防左室功能不全）BoschEnalapril和卡维地洛用于预防化疗引起的恶性血液病患者的左室收缩功能障碍。 OVERCOME试验（使用恩那普利和卡维地洛预防接受强化化学疗法治疗恶性血液病的患者左室功能不全）JACC61201323552362
8. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11; Heart Failure: Management of Patients with Left-Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians No. 11; Living with Heart Disease: Is It Heart Failure. Patient and Family Guide [R] . 1994

机译：心力衰竭：左心室收缩功能障碍患者的评估和护理。临床实践指南第11号;心力衰竭：左心室收缩功能障碍患者的治疗。临床医生快速参考指南第11号;与心脏病共存：是心衰吗？患者和家庭指南

著录项

相似文献

相关主题

期刊订阅